A 5:2 intermittent fasting diet combined with meal replacement resulted in greater weight loss and better glycemic control compared with antidiabetic medications in patients with early-stage type 2 diabetes, data from the EARLY study showed
Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease
Until fully implemented in 2027, CMS set up the Bridge to provide GLP-1 drugs for qualified individuals until the BALANCE Model was up and running
Whilst some individuals report noticing alterations in urine smell, these changes are typically related to other factors such as hydration status, dietary choices, blood glucose control, or underlying conditions like urinary tract infections
However, NAC is also not recommended for NAFLD in NICE guidance and should not be self-prescribed for liver diseaseyou should discuss this option with your GP or hepatologist before considering it
While it is only FDA approved for the treatment of diabetes, studies have shown it has promise in promoting weight loss, with people losing up to 10 pounds